![Cureus | Fluticasone Furoate/Vilanterol Use Trends and Characteristics in Patients With Obstructive Airway Disease: A Real-World Study of 10,374 Patients From India | Article Cureus | Fluticasone Furoate/Vilanterol Use Trends and Characteristics in Patients With Obstructive Airway Disease: A Real-World Study of 10,374 Patients From India | Article](https://assets.cureus.com/uploads/figure/file/541741/lightbox_c45fd64097c511eda91fd53d3c82df47-Fig-1.drawio-1-.png)
Cureus | Fluticasone Furoate/Vilanterol Use Trends and Characteristics in Patients With Obstructive Airway Disease: A Real-World Study of 10,374 Patients From India | Article
![α,β-Methylene-ADP (AOPCP) Derivatives and Analogues: Development of Potent and Selective ecto-5′-Nucleotidase (CD73) Inhibitors | Journal of Medicinal Chemistry α,β-Methylene-ADP (AOPCP) Derivatives and Analogues: Development of Potent and Selective ecto-5′-Nucleotidase (CD73) Inhibitors | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/acs.jmedchem.5b00802/asset/images/medium/jm-2015-00802k_0009.gif)
α,β-Methylene-ADP (AOPCP) Derivatives and Analogues: Development of Potent and Selective ecto-5′-Nucleotidase (CD73) Inhibitors | Journal of Medicinal Chemistry
![Cureus | Fluticasone Furoate/Vilanterol Use Trends and Characteristics in Patients With Obstructive Airway Disease: A Real-World Study of 10,374 Patients From India | Article Cureus | Fluticasone Furoate/Vilanterol Use Trends and Characteristics in Patients With Obstructive Airway Disease: A Real-World Study of 10,374 Patients From India | Article](https://assets.cureus.com/uploads/figure/file/541746/lightbox_2258b9e0a1eb11edb3a4bfc9c7c0f195-Fig2.png)
Cureus | Fluticasone Furoate/Vilanterol Use Trends and Characteristics in Patients With Obstructive Airway Disease: A Real-World Study of 10,374 Patients From India | Article
![Cureus | Fluticasone Furoate/Vilanterol Use Trends and Characteristics in Patients With Obstructive Airway Disease: A Real-World Study of 10,374 Patients From India | Authors Cureus | Fluticasone Furoate/Vilanterol Use Trends and Characteristics in Patients With Obstructive Airway Disease: A Real-World Study of 10,374 Patients From India | Authors](https://assets.cureus.com/uploads/figure/file/555244/lightbox_61a006a0a60811edbea61db33c7d0e3b-Fig4.png)
Cureus | Fluticasone Furoate/Vilanterol Use Trends and Characteristics in Patients With Obstructive Airway Disease: A Real-World Study of 10,374 Patients From India | Authors
![PAOK BC on Twitter: "Update: ALL SET! #PAOKARA #alltogetherpaok4ever https://t.co/e3BLd0QejV" / Twitter PAOK BC on Twitter: "Update: ALL SET! #PAOKARA #alltogetherpaok4ever https://t.co/e3BLd0QejV" / Twitter](https://pbs.twimg.com/ext_tw_video_thumb/1642191963733598208/pu/img/owLFgeCwwgDzS5U8.jpg)
PAOK BC on Twitter: "Update: ALL SET! #PAOKARA #alltogetherpaok4ever https://t.co/e3BLd0QejV" / Twitter
![PDF) The asthma-chronic obstructive pulmonary disease overlap syndrome: Pharmacotherapeutic considerations PDF) The asthma-chronic obstructive pulmonary disease overlap syndrome: Pharmacotherapeutic considerations](https://i1.rgstatic.net/publication/235894176_The_asthma-chronic_obstructive_pulmonary_disease_overlap_syndrome_Pharmacotherapeutic_considerations/links/542c48490cf277d58e8c7c64/largepreview.png)
PDF) The asthma-chronic obstructive pulmonary disease overlap syndrome: Pharmacotherapeutic considerations
![Colour online) Overlaid 1 H DOSY NMR spectra (500 MHz, d 6 -DMSO) of... | Download Scientific Diagram Colour online) Overlaid 1 H DOSY NMR spectra (500 MHz, d 6 -DMSO) of... | Download Scientific Diagram](https://www.researchgate.net/publication/284766885/figure/fig4/AS:934133723312128@1599726243264/Colour-online-Overlaid-1-H-DOSY-NMR-spectra-500-MHz-d-6-DMSO-of-Pd-2-diartripy-4.jpg)